SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-23-002732
Filing Date
2023-08-08
Accepted
2023-08-08 06:00:50
Documents
1
Period of Report
2023-08-08

Document Format Files

Seq Description Document Type Size
1 6-K zk2330126.htm 6-K 11723
  Complete submission text file 0001178913-23-002732.txt   12880
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38807 | Film No.: 231149152
SIC: 2834 Pharmaceutical Preparations